What is the prevalence of strabismus (crossed eyes) in the US and globally?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prevalence of Strabismus in the US and Globally

Strabismus affects approximately 4% of adults in the United States, with varying prevalence rates globally ranging from 1.9% to 2.65% depending on population and region. 1

US Prevalence Data

Children

  • In the Baltimore Pediatric Eye Disease Study:
    • 3.3% of white children and 2.1% of African American children aged 6-71 months had manifest strabismus 2
    • Higher rates (5.8% for whites and 2.9% for African Americans) were observed in children 60-71 months of age 2
    • National projections suggest approximately 677,000 cases of manifest strabismus among US children 6-71 months 2

Adults

  • The estimated incidence is 4% in the adult population 1
  • New-onset adult strabismus has an annual incidence of 6.0 per 100,000 people, with divergence insufficiency representing 10.6% of these cases 1
  • Sagging eye syndrome as a cause of acquired diplopia increases with age:
    • Less than 5% under age 50
    • Up to 60% over age 90 1

Global Prevalence

A comprehensive systematic review and meta-analysis of global strabismus prevalence found:

  • Pooled global prevalence of any strabismus: 1.93% (1.64-2.21%) 3
  • Exotropia prevalence: 1.23% (1.00-1.46%) 3
  • Esotropia prevalence: 0.77% (0.59-0.95%) 3

Regional Variations

  • Significant regional differences exist in strabismus prevalence worldwide 3
  • In Japan, strabismus fixus has been estimated at 2.65% among high myopes 1
  • The prevalence varies by WHO region, which was identified as a significant factor affecting heterogeneity in strabismus rates 3

Age and Demographic Factors

  • Age significantly affects the prevalence of exotropia 3
  • Divergence insufficiency typically presents after age 50 and increases with age 1
  • Median age of presentation for divergence insufficiency is 74 years 1
  • Divergence insufficiency is significantly more common among Caucasian women 1
  • Sagging eye syndrome occurs more frequently in females (54%) and myopes, with most patients presenting between 60-80 years of age 1

Common Types of Strabismus

In a population-based study in Olmsted County, Minnesota, the most common forms of childhood strabismus were:

  • Accommodative esotropia (27.9%)
  • Intermittent exotropia (16.9%)
  • Acquired nonaccommodative esotropia (10.2%)
  • Esotropia in children with abnormal central nervous system (7.0%)
  • Convergence insufficiency (6.4%) 4

Clinical Implications

Strabismus has significant impacts on quality of life:

  • Children with strabismus show reduced functional vision and eye-related quality of life 5
  • Parents of children with strabismus also experience reduced quality of life 5
  • The greatest differences between children with strabismus and visually normal controls were in functional vision domains 5

Important Considerations

  • Prevalence estimates vary based on study methodology, definitions of strabismus, and populations studied
  • Publication year affects heterogeneity in exotropia prevalence, suggesting changing patterns over time 3
  • Early identification and treatment are important as strabismus can impact visual function, binocularity, and psychosocial development
  • Strabismus in adults often does not resolve spontaneously and may be progressive, particularly strabismus fixus 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.